A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP
Clinical trial NCT02741388 · COMPLETED
Trial details
- NCT number
- NCT02741388
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2021-09-29
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.